T


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 18 09 2020
accepted: 07 12 2020
entrez: 15 2 2021
pubmed: 16 2 2021
medline: 24 6 2021
Statut: epublish

Résumé

T follicular helper (T

Identifiants

pubmed: 33584682
doi: 10.3389/fimmu.2020.608003
pmc: PMC7876074
doi:

Substances chimiques

Membrane Glycoproteins 0
SAIDS Vaccines 0
Viral Envelope Proteins 0
gp120 protein, Simian immunodeficiency virus 0

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

608003

Informations de copyright

Copyright © 2021 Helmold Hait, Hogge, Rahman, Hunegnaw, Mushtaq, Hoang and Robert-Guroff.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Immunity. 2011 Jan 28;34(1):108-21
pubmed: 21215658
J Immunol. 2009 Dec 1;183(11):7314-25
pubmed: 19917681
J Virol. 2014 Nov;88(22):13310-21
pubmed: 25210168
Curr Opin HIV AIDS. 2010 Sep;5(5):386-90
pubmed: 20978378
Hum Vaccin Immunother. 2017 May 4;13(5):1018-1030
pubmed: 28281871
Trends Immunol. 2014 Sep;35(9):436-42
pubmed: 24998903
J Cell Mol Med. 2018 Nov;22(11):5682-5687
pubmed: 30191661
Nat Chem Biol. 2010 Dec;6(12):887-9
pubmed: 20953192
Vaccine. 2003 Sep 8;21(25-26):4022-35
pubmed: 12922139
Curr Opin HIV AIDS. 2014 May;9(3):235-41
pubmed: 24670319
Nat Med. 2020 Jun;26(6):932-940
pubmed: 32393800
Immunity. 2014 Oct 16;41(4):529-42
pubmed: 25367570
J Immunol Methods. 2012 Jan 31;375(1-2):148-58
pubmed: 22019644
Cell Host Microbe. 2015 Feb 11;17(2):153-63
pubmed: 25620548
Nature. 2008 Oct 2;455(7213):613-9
pubmed: 18833271
J Immunol. 2006 Oct 1;177(7):4927-32
pubmed: 16982935
Nature. 2014 May 29;509(7502):573-4
pubmed: 24870540
Trends Immunol. 2014 Jun;35(6):278-86
pubmed: 24703588
Front Immunol. 2014 Mar 19;5:85
pubmed: 24678309
EBioMedicine. 2018 May;31:25-35
pubmed: 29685793
J Virol. 2018 Jul 17;92(15):
pubmed: 29793949
J Virol. 1997 Nov;71(11):8531-41
pubmed: 9343211
J Med Primatol. 2018 Oct;47(5):288-297
pubmed: 30204253
J Immunol. 2020 Jun 15;204(12):3315-3328
pubmed: 32393514
J Immunol. 2011 May 15;186(10):5556-68
pubmed: 21471443
J Exp Med. 2017 Jul 3;214(7):2139-2152
pubmed: 28637884
Immunity. 2013 Oct 17;39(4):758-69
pubmed: 24035365
Front Immunol. 2018 Oct 25;9:2469
pubmed: 30410492
J Immunol. 2016 Feb 15;196(4):1700-10
pubmed: 26773147
J Immunol Methods. 2011 Jan 5;363(2):166-76
pubmed: 20875419
Methods Mol Biol. 2015;1291:187-97
pubmed: 25836312
Immunol Rev. 2003 Aug;194:8-18
pubmed: 12846803
Annu Rev Immunol. 2011;29:621-63
pubmed: 21314428
Immunity. 2009 Mar 20;30(3):324-35
pubmed: 19303387
J Immunol. 2016 Sep 1;197(5):1832-42
pubmed: 27481845
Hum Vaccin Immunother. 2014;10(7):1985-92
pubmed: 25424808
Sci Rep. 2018 Feb 9;8(1):2729
pubmed: 29426881
J Immunol. 2009 Aug 15;183(4):2827-36
pubmed: 19635903
mBio. 2018 May 8;9(3):
pubmed: 29739909
J Immunol. 2007 Nov 1;179(9):5886-96
pubmed: 17947662
J Virol. 1992 Nov;66(11):6721-7
pubmed: 1404612
Scand J Immunol. 1993 Nov;38(5):428-34
pubmed: 8235446
J Virol. 2004 Mar;78(5):2212-21
pubmed: 14963117
J Virol. 2019 May 1;93(10):
pubmed: 30842321
N Engl J Med. 2012 Apr 5;366(14):1275-86
pubmed: 22475592
Front Immunol. 2017 Nov 15;8:1581
pubmed: 29176985
Immunity. 2011 Jun 24;34(6):932-46
pubmed: 21636296
J Clin Invest. 2019 Jul 2;129(8):3185-3200
pubmed: 31264971
Sci Rep. 2019 Jul 12;9(1):10090
pubmed: 31300682
EBioMedicine. 2020 Apr;54:102727
pubmed: 32268275
J Immunol. 2009 Sep 1;183(5):3139-49
pubmed: 19666691
PLoS Pathog. 2011 Jan 13;7(1):e1001251
pubmed: 21249232
Immunity. 2013 Oct 17;39(4):770-81
pubmed: 24138884
Science. 2013 Aug 9;341(6146):673-7
pubmed: 23887872
Retrovirology. 2018 Jul 28;15(1):52
pubmed: 30055627
Nat Immunol. 2011 Jun;12(6):472-7
pubmed: 21739669
Curr Opin Immunol. 2014 Jun;28:90-6
pubmed: 24681449
PLoS One. 2018 Nov 14;13(11):e0205139
pubmed: 30427829
J Clin Invest. 2010 Nov;120(11):3878-90
pubmed: 20972331
J Exp Med. 2013 Jan 14;210(1):143-56
pubmed: 23254284
F1000Res. 2016 May 25;5:
pubmed: 27303636
Immunity. 2018 Aug 21;49(2):264-274.e4
pubmed: 30076099
Sci Transl Med. 2015 Jul 29;7(298):298ra120
pubmed: 26223303
N Engl J Med. 2009 Dec 3;361(23):2209-20
pubmed: 19843557
Front Immunol. 2012 Jan 24;3:2
pubmed: 22566888
Curr Opin HIV AIDS. 2013 Jul;8(4):326-32
pubmed: 23743722
J Immunol. 2016 Aug 1;197(3):994-1002
pubmed: 27335502
Pathog Dis. 2019 Jun 1;77(4):
pubmed: 31505637
Immunol Rev. 2017 Jan;275(1):49-61
pubmed: 28133798
Nat Rev Immunol. 2015 Mar;15(3):137-48
pubmed: 25656706
J Immunol. 2016 Sep 15;197(6):2316-24
pubmed: 27534560
Immunity. 2013 Oct 17;39(4):629-30
pubmed: 24138878
JCI Insight. 2017 Jan 26;2(2):e89574
pubmed: 28138558
Retrovirology. 2018 Aug 6;15(1):54
pubmed: 30081906
Immunity. 2018 Jan 16;48(1):133-146.e6
pubmed: 29287996
J Immunol. 2012 Apr 1;188(7):3247-56
pubmed: 22387550
J Virol. 2020 Feb 28;94(6):
pubmed: 31827000
Eur J Immunol. 2020 Jun;50(6):783-794
pubmed: 32065660
J Virol. 2019 Feb 5;93(4):
pubmed: 30463978
Methods Mol Biol. 2015;1291:209-26
pubmed: 25836314
Immunol Rev. 2016 Mar;270(1):8-19
pubmed: 26864101
Vaccines (Basel). 2019 Nov 23;7(4):
pubmed: 31771162
Int Rev Immunol. 2009;28(1):20-48
pubmed: 19241252
Eur J Immunol. 2017 Jul;47(7):1136-1141
pubmed: 28586108
Adv Immunol. 2010;105:193-210
pubmed: 20510734
Sci Rep. 2017 Dec 1;7(1):16799
pubmed: 29196729
Science. 2015 Jul 17;349(6245):320-4
pubmed: 26138104
Cell Rep. 2016 Nov 22;17(9):2195-2209
pubmed: 27880897
J Exp Med. 2012 Oct 22;209(11):2079-97
pubmed: 23027924
Cytometry A. 2013 Aug;83(8):692-701
pubmed: 23788442
Immunity. 2019 May 21;50(5):1132-1148
pubmed: 31117010
Front Immunol. 2017 Feb 20;8:135
pubmed: 28265271
PLoS Pathog. 2015 Aug 12;11(8):e1005101
pubmed: 26267144
J Clin Immunol. 2016 May;36 Suppl 1:34-9
pubmed: 26984851
Annu Rev Immunol. 1994;12:117-39
pubmed: 8011279
Mucosal Immunol. 2009 Nov;2(6):536-50
pubmed: 19741603
Immunity. 2016 Jan 19;44(1):167-178
pubmed: 26795249
J Leukoc Biol. 2015 Jan;97(1):19-30
pubmed: 25341725
Front Immunol. 2017 Jan 30;8:46
pubmed: 28194154
F1000Res. 2016 Jan 20;5:
pubmed: 26989476
J Virol. 2015 Dec 16;90(6):2718-28
pubmed: 26676775
J Immunol. 2015 Aug 1;195(3):994-1005
pubmed: 26116502
BMC Immunol. 2016 Oct 21;17(1):40
pubmed: 27769184
J Leukoc Biol. 2017 Aug;102(2):527-536
pubmed: 28550121
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2639-44
pubmed: 12604779
Nat Rev Immunol. 2015 Mar;15(3):185-9
pubmed: 25677493
J Virol. 2012 Dec;86(23):12591-604
pubmed: 22973034
J Virol. 2008 Nov;82(21):10911-21
pubmed: 18753198
Front Immunol. 2018 Sep 12;9:1975
pubmed: 30258437

Auteurs

Sabrina Helmold Hait (S)

Immune Biology of Retroviral Infection Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Christopher James Hogge (CJ)

Immune Biology of Retroviral Infection Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Mohammad Arif Rahman (MA)

Immune Biology of Retroviral Infection Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Ruth Hunegnaw (R)

Immune Biology of Retroviral Infection Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Zuena Mushtaq (Z)

Immune Biology of Retroviral Infection Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Tanya Hoang (T)

Immune Biology of Retroviral Infection Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Marjorie Robert-Guroff (M)

Immune Biology of Retroviral Infection Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH